BibTex RIS Cite

Assessment of cardiac involvement by non-invasive electrophysiological

Year 2010, Volume: 37 Issue: 3, 228 - 235, 01.09.2010

Figen Ceylan Çevik Selma Yazıcı Mehmet Tahtasız Ali Fuad Kara Habib Çil Zuhal Atılgan Ebru Tekbas A. Jale Saraç

Abstract

Objective: Cardiac involvement occurs due to the disease itself and secondary to the used drugs, and commonly develops silent in rheumatoid arthritis (RA). In this study, it was investigated the presence of cardiac involvement by non-invasive electrophysiological parameters. Materials and Methods: 49 patients with RA and agematched 28 healthy subjects as control group were enrolled to this study. Clinical and laboratory parameters of all subjects were assessed and 24-hour electrocardiographic Holter monitoring were performed. Results: Minimum, maximum and mean heart rate were signifi cantly higher (p

Keywords

Rheumatoid arthritis Holter electrocardiography QT dispersion heart rate variability.

References

  • Wallberg JS, Ohman Ml. Cardiovascular morbidity and mor- tality in patients with seropositive Rheumatoid arthritis. J Rheumatol 1997; 24: 445-51.
  • Jacobsson LTH, Knowler WC, Pillemar S, et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indi- ans. Arthritis Rheum 1993;36:1045-53.
  • Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Isomäki H. Cardiovascular mortality in women with rheumatoid ar- thritis. J Rheumatol 1995;22:1065-7.
  • Maione S, Valentin G, Giunta A. Cardiac involvement in rheumatoid arthritis: an echocardiographic study. Cardiol- ogy 1993;83:234-9.
  • Roberts WC, Kehoe JA, Carpenter DF, et al. Cardiac val- vular lesions in rheumatoid arthritis. Arch Intern Med 1968;122:141-6.
  • Leibowitz WB. The heart in rheumatoid arthritis. A clini- cal and pathological study of 62 cases. Ann Intern Med 1963;58:102-23.
  • Mandell BF, Hoffman GS. Rheumatic Diseases and the Car- diovascular System. In: Zipes DP, Libby P, Bonow RO, Braunwald E (Eds.). Braunwald’s Heart Disease, a textbook of Cardiovascular Medicine. 7th ed. Philadelphia: Elsevier Saunders; 2005. p.2101-16
  • del Rincon I, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
  • Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Ar- thritis Rheum 2005; 52: 402-11.
  • Dessein PH, Joffe BI. When is a patient with rheumatoid ar- thritis at risk for cardiovascular disease? J Rheumatol 2006; 33: 201-3.
  • Karjalainen J, Reunanen A, Ristola P. QT interval as a cardiac risk factor in a middle aged population. Heart 1997;77:543-8.
  • Puddu P E, Bourassa MG. Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol 1986; 19:203-11.
  • Pirildar T, Sekuri C, Utük O, Tezcan UK. QT dispersion in rheumatoid arthritis patients with and without Sjögren’s syndrome. Clin Rheumatol 2003;22:225-8.
  • Göldeli O, Dursun E, Komsuoglu B. Dispersion of ven- tricular repolarization: a new marker of ventricular arrhyth- mias in patients with rheumatoid arthritis. J Rheumatol 1998;25:447-50.
  • Alpaslan M, Alpaslan S, Ornat E. QT dispersion ın rheuma- toid arthritis. J Ankara Med School 2001;23: 137-42.
  • Alkaabi JK, Ho M, Levison R, Pullar T. Belch JJ. Rheu- matoid arthritis and macrovascular disease. Rheumatology 2003;42:292-7.
  • Wislowska M, Sypula S, Kowalik I. Echocardiographic Ş ndings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthri- tis. Rheumatol Int 1999;18:163-9.
  • Wislowska M, Sypula S, Kowalik I. Echocardiographic Ş ndings and 24-h electrocardiographic Holter monitoring in patients with Rheumatoid Arthritis according to Stein- brocker’s criteria, functional index, value of wailer- rose titre and duration of disease. Clin Rheumatol 1998;17: 369- 77.
  • Dilaveris PE, Gialafos EJ, Sideris S, et al. Simple electro- cardiographic markers for the prediction of paroxysmal id- iopathic atrial fi brillation. Am Heart J 1998;135:733-8.
  • Tukek T, Akkaya V, Demirel S, et al. Effect of Valsalva maneuver on surface electrocardiographic P-wave dis- persion in paroxysmal atrial fi brillation. Am J Cardiol 2000;85:896-9.
  • Aytemir K, Amasyali B, Abali G, et al. The signal-averaged P-wave duration is longer in hypertensive patients with his- tory of paroxysmal atrial fi brillation as compared to those without. Int J Cardiol 2005;103:37-40.
  • Guler H, Seyfeli E, Sahin G, et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int 2007;27: 813-8.
  • Arnett FC, Edwothy SM, Bloch DA, Meshane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 criteria for the classifi cation of rheumatoid arthritis. Arthri- tis Rheum 1988;31:315-24.
  • Henry WL, DeMaria A, Gramiak R, et al. Report of the American society of echocardiography committee on no- menclature and standards in two dimensional imaging. Cir- culation 1980;62:212-7.
  • Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36: 1749-66.
  • Evrengul H, Dursunoglu D, Cobankara N, et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 2004;24:198-202.
  • Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ. Elevated sympathetic nervous system activ- ity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 2004;22:63-70.
  • Gunduz H, Binak E, Arinc H, et al. The relationship be- tween P wave dispersion and diastolic dysfunction. Texas Heart Inst J 2005; 32:163-7.

Romatoid artritli hastalarda kardiyak tutulumun noninvaziv elektrofi zyolojik parametrelerle değerlendirilmesi

Year 2010, Volume: 37 Issue: 3, 228 - 235, 01.09.2010

Figen Ceylan Çevik Selma Yazıcı Mehmet Tahtasız Ali Fuad Kara Habib Çil Zuhal Atılgan Ebru Tekbas A. Jale Saraç

Abstract

Amaç: Romatoid artrit (RA)\'te hem hastalığa ve hem de kullanılan ilaçlara bağlı olarak kalp tutulumu olabilmekte ve çoğunlukla sessiz seyretmektedir. Bu çalısmada RA\'li hastalarda non-invaziv elektrofi zyolojik parametreler aracılığıyla kardiyak etkilenimin varlığı arastırıldı. Gereç ve yöntemler: Bu çalısmaya benzer yasta 49 RA\'li hasta ve 28 sağlıklı birey kontrol grubu olarak alındı. Tüm bireyler klinik ve laboratuar parametreleri açısından değerlendirildi ve 24 saatlik Holter elektrokardiografi k monitorizasyonları yapıldı. Bulgular: Maksimum QT aralığı kontrollere göre RA\'lı hastalarda daha düsük iken (p

Keywords

Romatoid artrit Holter elektrokardiografi QT dispersiyonu kalp hızı değişkenliği

References

  • Wallberg JS, Ohman Ml. Cardiovascular morbidity and mor- tality in patients with seropositive Rheumatoid arthritis. J Rheumatol 1997; 24: 445-51.
  • Jacobsson LTH, Knowler WC, Pillemar S, et al. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indi- ans. Arthritis Rheum 1993;36:1045-53.
  • Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Isomäki H. Cardiovascular mortality in women with rheumatoid ar- thritis. J Rheumatol 1995;22:1065-7.
  • Maione S, Valentin G, Giunta A. Cardiac involvement in rheumatoid arthritis: an echocardiographic study. Cardiol- ogy 1993;83:234-9.
  • Roberts WC, Kehoe JA, Carpenter DF, et al. Cardiac val- vular lesions in rheumatoid arthritis. Arch Intern Med 1968;122:141-6.
  • Leibowitz WB. The heart in rheumatoid arthritis. A clini- cal and pathological study of 62 cases. Ann Intern Med 1963;58:102-23.
  • Mandell BF, Hoffman GS. Rheumatic Diseases and the Car- diovascular System. In: Zipes DP, Libby P, Bonow RO, Braunwald E (Eds.). Braunwald’s Heart Disease, a textbook of Cardiovascular Medicine. 7th ed. Philadelphia: Elsevier Saunders; 2005. p.2101-16
  • del Rincon I, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
  • Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Ar- thritis Rheum 2005; 52: 402-11.
  • Dessein PH, Joffe BI. When is a patient with rheumatoid ar- thritis at risk for cardiovascular disease? J Rheumatol 2006; 33: 201-3.
  • Karjalainen J, Reunanen A, Ristola P. QT interval as a cardiac risk factor in a middle aged population. Heart 1997;77:543-8.
  • Puddu P E, Bourassa MG. Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol 1986; 19:203-11.
  • Pirildar T, Sekuri C, Utük O, Tezcan UK. QT dispersion in rheumatoid arthritis patients with and without Sjögren’s syndrome. Clin Rheumatol 2003;22:225-8.
  • Göldeli O, Dursun E, Komsuoglu B. Dispersion of ven- tricular repolarization: a new marker of ventricular arrhyth- mias in patients with rheumatoid arthritis. J Rheumatol 1998;25:447-50.
  • Alpaslan M, Alpaslan S, Ornat E. QT dispersion ın rheuma- toid arthritis. J Ankara Med School 2001;23: 137-42.
  • Alkaabi JK, Ho M, Levison R, Pullar T. Belch JJ. Rheu- matoid arthritis and macrovascular disease. Rheumatology 2003;42:292-7.
  • Wislowska M, Sypula S, Kowalik I. Echocardiographic Ş ndings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthri- tis. Rheumatol Int 1999;18:163-9.
  • Wislowska M, Sypula S, Kowalik I. Echocardiographic Ş ndings and 24-h electrocardiographic Holter monitoring in patients with Rheumatoid Arthritis according to Stein- brocker’s criteria, functional index, value of wailer- rose titre and duration of disease. Clin Rheumatol 1998;17: 369- 77.
  • Dilaveris PE, Gialafos EJ, Sideris S, et al. Simple electro- cardiographic markers for the prediction of paroxysmal id- iopathic atrial fi brillation. Am Heart J 1998;135:733-8.
  • Tukek T, Akkaya V, Demirel S, et al. Effect of Valsalva maneuver on surface electrocardiographic P-wave dis- persion in paroxysmal atrial fi brillation. Am J Cardiol 2000;85:896-9.
  • Aytemir K, Amasyali B, Abali G, et al. The signal-averaged P-wave duration is longer in hypertensive patients with his- tory of paroxysmal atrial fi brillation as compared to those without. Int J Cardiol 2005;103:37-40.
  • Guler H, Seyfeli E, Sahin G, et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int 2007;27: 813-8.
  • Arnett FC, Edwothy SM, Bloch DA, Meshane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 criteria for the classifi cation of rheumatoid arthritis. Arthri- tis Rheum 1988;31:315-24.
  • Henry WL, DeMaria A, Gramiak R, et al. Report of the American society of echocardiography committee on no- menclature and standards in two dimensional imaging. Cir- culation 1980;62:212-7.
  • Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000; 36: 1749-66.
  • Evrengul H, Dursunoglu D, Cobankara N, et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 2004;24:198-202.
  • Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ. Elevated sympathetic nervous system activ- ity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 2004;22:63-70.
  • Gunduz H, Binak E, Arinc H, et al. The relationship be- tween P wave dispersion and diastolic dysfunction. Texas Heart Inst J 2005; 32:163-7.
There are 28 citations in total.

Details

Primary Language Turkish
Journal Section Research Articles
Authors

Figen Ceylan Çevik This is me

Selma Yazıcı This is me

Mehmet Tahtasız This is me

Ali Fuad Kara This is me

Habib Çil This is me

Zuhal Atılgan This is me

Ebru Tekbas This is me

A. Jale Saraç This is me

Publication Date September 1, 2010
Submission Date March 2, 2015
Published in Issue Year 2010 Volume: 37 Issue: 3

Cite

APA Çevik, F. C., Yazıcı, S., Tahtasız, M., Kara, A. F., et al. (2010). Romatoid artritli hastalarda kardiyak tutulumun noninvaziv elektrofi zyolojik parametrelerle değerlendirilmesi. Dicle Tıp Dergisi, 37(3), 228-235.
AMA Çevik FC, Yazıcı S, Tahtasız M, Kara AF, Çil H, Atılgan Z, Tekbas E, Saraç AJ. Romatoid artritli hastalarda kardiyak tutulumun noninvaziv elektrofi zyolojik parametrelerle değerlendirilmesi. diclemedj. September 2010;37(3):228-235.
Chicago Çevik, Figen Ceylan, Selma Yazıcı, Mehmet Tahtasız, Ali Fuad Kara, Habib Çil, Zuhal Atılgan, Ebru Tekbas, and A. Jale Saraç. “Romatoid Artritli Hastalarda Kardiyak Tutulumun Noninvaziv Elektrofi Zyolojik Parametrelerle değerlendirilmesi”. Dicle Tıp Dergisi 37, no. 3 (September 2010): 228-35.
EndNote Çevik FC, Yazıcı S, Tahtasız M, Kara AF, Çil H, Atılgan Z, Tekbas E, Saraç AJ (September 1, 2010) Romatoid artritli hastalarda kardiyak tutulumun noninvaziv elektrofi zyolojik parametrelerle değerlendirilmesi. Dicle Tıp Dergisi 37 3 228–235.
IEEE F. C. Çevik, S. Yazıcı, M. Tahtasız, A. F. Kara, H. Çil, Z. Atılgan, E. Tekbas, and A. J. Saraç, “Romatoid artritli hastalarda kardiyak tutulumun noninvaziv elektrofi zyolojik parametrelerle değerlendirilmesi”, diclemedj, vol. 37, no. 3, pp. 228–235, 2010.
ISNAD Çevik, Figen Ceylan et al. “Romatoid Artritli Hastalarda Kardiyak Tutulumun Noninvaziv Elektrofi Zyolojik Parametrelerle değerlendirilmesi”. Dicle Tıp Dergisi 37/3 (September 2010), 228-235.
JAMA Çevik FC, Yazıcı S, Tahtasız M, Kara AF, Çil H, Atılgan Z, Tekbas E, Saraç AJ. Romatoid artritli hastalarda kardiyak tutulumun noninvaziv elektrofi zyolojik parametrelerle değerlendirilmesi. diclemedj. 2010;37:228–235.
MLA Çevik, Figen Ceylan et al. “Romatoid Artritli Hastalarda Kardiyak Tutulumun Noninvaziv Elektrofi Zyolojik Parametrelerle değerlendirilmesi”. Dicle Tıp Dergisi, vol. 37, no. 3, 2010, pp. 228-35.
Vancouver Çevik FC, Yazıcı S, Tahtasız M, Kara AF, Çil H, Atılgan Z, Tekbas E, Saraç AJ. Romatoid artritli hastalarda kardiyak tutulumun noninvaziv elektrofi zyolojik parametrelerle değerlendirilmesi. diclemedj. 2010;37(3):228-35.